Clinical Trial Update: Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 trial evaluates hyperthermic intraperitoneal chemotherapy (HIPEC) as first-line therapy for patients with Stage III ovarian cancer or S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Jules Bordet Institute | Conditions: Ovarian Carcinoma, Fallopian Tube Carcinoma | Phase 1, Phase 2 | Status: COMPLETED